CompletedPhase 2NCT00525902

Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oregon Health and Science University
Principal Investigator
Eric B Suhler, MD
Oregon Health and Science University
Intervention
Adalimumab(drug)
Enrollment
31 target
Eligibility
18 years · All sexes
Timeline
20082010

Study locations (1)

Collaborators

University of Illinois at Chicago · The Cleveland Clinic

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00525902 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials